FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38909711000001106: Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1586161000001118 Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1586171000001111 Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet Has VMP Alpelisib 50mg tablets and Alpelisib 200mg tablets true Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Piqray 50mg tablets and Piqray 200mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 1 x (28 tablets + 28 tablets) Is a True Alpelisib 50mg tablets and Alpelisib 200mg tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start